The healthcare community is buzzing about Retatrutide 120 , a dual-action therapy showing significant results in clinical studies . This innovative compound, a glucagon-like peptide-1 receptor agonist alongside a glucose-dependent insulinotropic compound, appears to substantially reduce body weight and positively affect metabolic function . Experts